Skip to main content
NCBI home page
Skull Base Surgery logoLink to Skull Base Surgery
. 1994 Jul;4(3):127–131. doi: 10.1055/s-2008-1058963

Management of Unresectable Malignant Tumors at the Skull Base Using Concomitant Chemotherapy and Radiotherapy with Accelerated Fractionation

Louis B Harrison, David G Pfister, Dennis Kraus, John G Armstrong, Michael J Zelefsky, Jill Wiseberg, George J Bosl, Elliot W Strong, Jatin P Shah
PMCID: PMC1661798  PMID: 17171161

Abstract

Between January 1988 and June 1992, 20 patients with unresectable malignant tumors at the skull base were treated. Eleven had T4 lesions of the paranasal sinus/cavity complex, and 9 had T4 nasopharynx cancer. All patients had stage IV disease by the American Joint Committee on Staging Criteria. The histology was squamous cell cancer in 15 patients and other minor salivary gland histologies in 5. There was brain and/or dural invasion in 11 patients and orbital invasion in 9. All patients received radiation therapy with accelerated fractionation to a total of 70 Gy in 6 weeks. Concomitant cisplatin (100 mg/m2) was given on days 1 and 22 of radiation. Seven patients received mitomycin C (7.5 mg/m2) on days 1 and 22, plus adjuvant chemotherapy with cisplatin and vinblastine. Median follow-up was 11 (range: 1 to 43) months. At 2 years, local progression-free survival was 94%, distant metastases-free survival was 57%, and overall survival was 80%. Complications occurred in 20% and caused the death of 1 patient. Treatment of this group of patients with aggressive chemotherapy and radiation therapy produced excellent local control in our early experience, but longer follow-up is needed. There is a high rate of distant failure. Future strategies are outlined.

Full text

PDF
127

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Sarraf M., Pajak T. F., Marcial V. A., Mowry P., Cooper J. S., Stetz J., Ensley J. F., Velez-Garcia E. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study. Cancer. 1987 Jan 15;59(2):259–265. doi: 10.1002/1097-0142(19870115)59:2<259::aid-cncr2820590214>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  2. Bedwinek J. M., Perez C. A., Keys D. J. Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx. Cancer. 1980 Jun 1;45(11):2725–2729. doi: 10.1002/1097-0142(19800601)45:11<2725::aid-cncr2820451105>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  3. Ervin T. J., Clark J. R., Weichselbaum R. R., Fallon B. G., Miller D., Fabian R. L., Posner M. R., Norris C. M., Jr, Tuttle S. A., Schoenfeld D. A. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol. 1987 Jan;5(1):10–20. doi: 10.1200/JCO.1987.5.1.10. [DOI] [PubMed] [Google Scholar]
  4. Fu K. K., Phillips T. L., Silverberg I. J., Jacobs C., Goffinet D. R., Chun C., Friedman M. A., Kohler M., McWhirter K., Carter S. K. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol. 1987 Sep;5(9):1410–1418. doi: 10.1200/JCO.1987.5.9.1410. [DOI] [PubMed] [Google Scholar]
  5. Harrison L. B., Pfister D. G., Fass D. E., Armstrong J. G., Sessions R. B., Shah J. P., Spiro R. H., Strong E. W., Weisen S., Bosl G. J. Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):703–708. doi: 10.1016/0360-3016(91)90689-2. [DOI] [PubMed] [Google Scholar]
  6. Hoppe R. T., Portlock C. S., Glatstein E., Rosenberg S. A., Kaplan H. S. Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease. Cancer. 1979 Feb;43(2):472–481. doi: 10.1002/1097-0142(197902)43:2<472::aid-cncr2820430211>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  7. Hsu M. M., Huang S. C., Lynn T. C., Hsieh T., Tu S. M. The survival of patients with nasopharyngeal carcinoma. Otolaryngol Head Neck Surg. 1982 May-Jun;90(3 Pt 1):289–295. [PubMed] [Google Scholar]
  8. Jackson I. T., Bailey M. H., Marsh W. R., Juhasz P. Results and prognosis following surgery for malignant tumors of the skull base. Head Neck. 1991 Mar-Apr;13(2):89–96. doi: 10.1002/hed.2880130202. [DOI] [PubMed] [Google Scholar]
  9. Jacobs C., Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J Clin Oncol. 1990 May;8(5):838–847. doi: 10.1200/JCO.1990.8.5.838. [DOI] [PubMed] [Google Scholar]
  10. Kraus D. H., Sterman B. M., Levine H. L., Wood B. G., Tucker H. M., Lavertu P. Factors influencing survival in ethmoid sinus cancer. Arch Otolaryngol Head Neck Surg. 1992 Apr;118(4):367–372. doi: 10.1001/archotol.1992.01880040025005. [DOI] [PubMed] [Google Scholar]
  11. Leitner S. P., Bosl G. J., Strong E. W., Gerold F. P., Spiro R. H., Shah J. P., Sessions R. B., Vikram B. A pilot study of cisplatin-vinblastine as the initial treatment of advanced head and neck cancer. Cancer. 1986 Sep 1;58(5):1014–1017. doi: 10.1002/1097-0142(19860901)58:5<1014::aid-cncr2820580504>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  12. Marcial V. A. Ninth annual del Regato lecture: optimal multidisciplinary management of head and neck cancer. Int J Radiat Oncol Biol Phys. 1987 Mar;13(3):393–401. doi: 10.1016/0360-3016(87)90014-9. [DOI] [PubMed] [Google Scholar]
  13. Marcial V. A., Pajak T. F., Mohiuddin M., Cooper J. S., al Sarraf M., Mowry P. A., Curran W., Crissman J., Rodríguez M., Vélez-García E. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer. 1990 Nov 1;66(9):1861–1868. doi: 10.1002/1097-0142(19901101)66:9<1861::aid-cncr2820660902>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  14. Merlano M., Vitale V., Rosso R., Benasso M., Corvò R., Cavallari M., Sanguineti G., Bacigalupo A., Badellino F., Margarino G. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med. 1992 Oct 15;327(16):1115–1121. doi: 10.1056/NEJM199210153271602. [DOI] [PubMed] [Google Scholar]
  15. Mesic J. B., Fletcher G. H., Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys. 1981 Apr;7(4):447–453. doi: 10.1016/0360-3016(81)90129-2. [DOI] [PubMed] [Google Scholar]
  16. Shah J. P., Kraus D. H., Arbit E., Galicich J. H., Strong E. W. Craniofacial resection for tumors involving the anterior skull base. Otolaryngol Head Neck Surg. 1992 Apr;106(4):387–393. doi: 10.1177/019459989210600412. [DOI] [PubMed] [Google Scholar]
  17. Weissberg J. B., Son Y. H., Papac R. J., Sasaki C., Fischer D. B., Lawrence R., Rockwell S., Sartorelli A. C., Fischer J. J. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):3–9. doi: 10.1016/0360-3016(89)90362-3. [DOI] [PubMed] [Google Scholar]

Articles from Skull base surgery are provided here courtesy of Thieme Medical Publishers

RESOURCES